229 related articles for article (PubMed ID: 10657950)
1. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.
Bianco T; Chenevix-Trench G; Walsh DC; Cooper JE; Dobrovic A
Carcinogenesis; 2000 Feb; 21(2):147-51. PubMed ID: 10657950
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
Baldwin RL; Nemeth E; Tran H; Shvartsman H; Cass I; Narod S; Karlan BY
Cancer Res; 2000 Oct; 60(19):5329-33. PubMed ID: 11034065
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 methylation: a significant role in tumour development?
Catteau A; Morris JR
Semin Cancer Biol; 2002 Oct; 12(5):359-371. PubMed ID: 12191635
[TBL] [Abstract][Full Text] [Related]
5. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).
Ruscito I; Dimitrova D; Vasconcelos I; Gellhaus K; Schwachula T; Bellati F; Zeillinger R; Benedetti-Panici P; Vergote I; Mahner S; Cacsire-Tong D; Concin N; Darb-Esfahani S; Lambrechts S; Sehouli J; Olek S; Braicu EI
Eur J Cancer; 2014 Aug; 50(12):2090-8. PubMed ID: 24889916
[TBL] [Abstract][Full Text] [Related]
8. High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.
Wilcox CB; Baysal BE; Gallion HH; Strange MA; DeLoia JA
Cancer Genet Cytogenet; 2005 Jun; 159(2):114-22. PubMed ID: 15899382
[TBL] [Abstract][Full Text] [Related]
9. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics.
Catteau A; Harris WH; Xu CF; Solomon E
Oncogene; 1999 Mar; 18(11):1957-65. PubMed ID: 10208417
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 promoter hypermethylation and protein expression in ovarian carcinoma--an Indian study.
Shilpa V; Bhagat R; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
Tumour Biol; 2014 May; 35(5):4277-84. PubMed ID: 24385383
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
Chan KY; Ozçelik H; Cheung AN; Ngan HY; Khoo US
Cancer Res; 2002 Jul; 62(14):4151-6. PubMed ID: 12124354
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
[TBL] [Abstract][Full Text] [Related]
14. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens.
Rice JC; Ozcelik H; Maxeiner P; Andrulis I; Futscher BW
Carcinogenesis; 2000 Sep; 21(9):1761-5. PubMed ID: 10964110
[TBL] [Abstract][Full Text] [Related]
15. DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter.
Butcher DT; Mancini-DiNardo DN; Archer TK; Rodenhiser DI
Int J Cancer; 2004 Sep; 111(5):669-78. PubMed ID: 15252835
[TBL] [Abstract][Full Text] [Related]
16. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 promoter methylation predicts adverse ovarian cancer prognosis.
Chiang JW; Karlan BY; Cass L; Baldwin RL
Gynecol Oncol; 2006 Jun; 101(3):403-10. PubMed ID: 16360812
[TBL] [Abstract][Full Text] [Related]
18. Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells.
Magdinier F; Billard LM; Wittmann G; Frappart L; Benchaïb M; Lenoir GM; Guérin JF; Dante R
FASEB J; 2000 Aug; 14(11):1585-94. PubMed ID: 10928993
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the BRCA1 gene in sporadic breast cancer.
Dobrovic A; Simpfendorfer D
Cancer Res; 1997 Aug; 57(16):3347-50. PubMed ID: 9269993
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.
Miyamoto K; Fukutomi T; Asada K; Wakazono K; Tsuda H; Asahara T; Sugimura T; Ushijima T
Jpn J Clin Oncol; 2002 Mar; 32(3):79-84. PubMed ID: 11956301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]